Commercialization: Page 39

PharmaVoice Team/PharmaVoice

UpFront

Industry at Large Daiichi Sankyo Provides Support to China Daiichi Sankyo has launched a new social contribution initiative through an international NGO, Plan Japan, in the rural areas of Yunnan Province in China. Daiichi Sankyo provides support to help improve the health of mothers and children...
By PharmaVoice Team • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Innovator's Corner

An App Store for Genomic Information Justin Kao, Senior VP of Corporate Development, Operations, and Strategy at Helix, talks about his company’s plans to build the infrastructure that gives consumers power and control over their genetic information. Imagine a time when consumers can access detai...
By Justin Kao • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

The Network

Wearables Market Continues to Expand Trending Now: Wearables technology is rapidly diversifying and growing globally. A Frost & Sullivan report, Growth Opportunities in the Global Wearable Devices Market, finds that wearable devices will play a large role in the healthcare industry delivering...
By PharmaVoice Team • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

What's New

Critical Path Institute Establishes the Global Pediatric Clinical Trials Network Pre-Launch Consortium Trending Now: New network is focused exclusively on pediatric trials. The Critical Path Institute (C-Path), a pioneering non-profit organization dedicated to accelerating the pace and reducing...
By PharmaVoice Team • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

The Calendar

Coming Attractions CNS Summit 2015 will take place Oct. 8 – Oct. 11 at the Boca Raton Resort & Club, Boca Raton, Fla. The CNS Summit is committed to collaboration among all stakeholders, with the objective of advancing drug development. It is in this spirit of collaboration that all CNS Summ...
By PharmaVoice Team • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Talent Pool

Pharma Pool Susan Benton Tracey Dawson Shire Appoints New Executive Team Leads Susan Benton, an industry veteran with more than 25 years of commercial business experience, including 17 years focused in ophthalmology, has been named head of business development, ophthalmics, Shire. She is responsi...
By PharmaVoice Team • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Last Word

Communications and Public Health Gil Bashe, Chair of the American Heart Association Founders’ Affiliate Northeastern Region and Head of Finn Partners’ health practice, talks about the intersection of public relations, communications, and public health. PV: What are the challenges facing public h...
By Gil Bashe • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Show Don't Tell: Messaging in the Digital Age

In 1911, a newspaper editor was the first to use the phrase “A picture is worth a thousand words," and the relevance of this statement remains today. More than 100 years later, it is even more important to represent a brand or brand message in as quick and visual a way as possible, especially onl...
By Robin Robinson • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Oncology Marketing Based On Value

As more payers turn to an indication-based or pay-for-performance based model to manage the costs of oncology care, oncology marketers will need to adjust their strategies to include a more holistic, value-based message. Across the globe, the trend toward more innovative payment models has altere...
By Robin Robinson • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Aging Well

With more than 10,000 people a day turning 65 in the United States, the industry is preparing to meet the demand of this older population. Two avenues include exploring regenerative medicine, and tailoring digital strategies to this online-savvy demographic. To meet the upcoming demand from the n...
By Robin Robinson • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Balancing Risk and Reward in Nigeria

As the largest economy in West Africa based on gross domestic product (GDP), Nigeria is emerging as an exciting market for all industries. According to 2013 figures, Nigeria’s GDP is around $500 billion, stronger even than South Africa with a GDP of around $350 billion. Today, Nigeria is the 26th...
By Kim Ribbink • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: Patient Solutions

Patient solutions can be as varied as the different stages of the disease “journey" that patients are experiencing: beginning with the first symptoms, continuing to diagnosis, then to treatment choice and optimization and eventually the improved life with disease. Additionally, all of those steps...
By Taren Grom • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Not all Rx Adherence Solutions are Created Equal

In a world where the majority — 60% to 80% — of people don’t follow their prescribed treatment, pharma manufacturers continue to struggle to address the health consequences and financial burden of non- adherence. Education, reminder tactics, points for prizes and gaming techniques; there are many...
By Jennifer Sigaud • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Bridging the Gap Between Patients and Providers for Better Health Outcomes

Pharma has expanded the scope of patient solutions in the marketplace, but most of these solutions remain product-focused. The emphasis is currently on product messaging or tools to make access to products more convenient and easier for the patient. Sure, these solutions can enhance the product e...
By Alyson Connor • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Mission No. 1: Making the World a Better Place

“The world would be a better place…" It’s a short phrase that can provoke powerful thought experiments… and can even transform the way we live. At Ogilvy, and Ogilvy CommonHealth Worldwide, we start all of our discussions with this simple framework. The world would be a better place, if… And whe...
By Johanna Skilling • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: Supply Chain

Prepare for impact: The $3 trillion supply chain shakeup is coming, ready or not. Analysts at Accenture say every business is now a digital business. But the question is: is every supply chain a truly digital supply chain? They say many companies are just putting digital processes on top of tradi...
By Taren Grom • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Distribution and 3PL: Adding Value with a Strategic, Integrated Approach

Q: What value can an end-to-end service value chain that touches all aspects of prescription medicine distribution and support bring to the market? A: An end-to-end service value chain that is truly comprehensive in nature can bring significant value, especially to virtual and emerging pharmaceut...
By Jeff Bedard • Oct. 1, 2015
PharmaVoice Team/PharmaVoice

Letter from the Editor

Patient-centric, patient-centricity, patients at the center…these buzzwords or terms are permeating the healthcare industry consciousness. Like Tom Hanks’ character in You’ve Got Mail, I too, believe most of life’s questions can be answered by the Godfather, so to paraphrase the Michael Corleone:...
By Taren Grom • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

Upfront

Lilly Launches Disney Book for Children Affected by Diabetes Lilly Diabetes has expanded its collection of resources for families of children with type 1 diabetes with the publication of Go, Team Coco! The story is the fourth Disney book in a series featuring Coco, a charismatic and fun-loving mo...
By PharmaVoice Team • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

What's New

BIO Renamed to Biotechnology Innovation Organization Trending now: Biotechnology Industry Organization rebrands to meet member focus. At the BIO 2015 International Convention this past June, new Board Chair Ron Cohen, CEO of Acorda Therapeutics, revealed that the Biotechnology Industry Organizat...
By PharmaVoice Team • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

Pharma Trax

Understanding of Therapeutic Value of Cancer Drugs Increases after Initial Approval Trending now: Ongoing research and real-world application post-approval often reveal greater benefit of cancer therapies. The full therapeutic value of a cancer therapy is typically realized long after the drug’s ...
By PharmaVoice Team • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

Tools of the Trade

First Medidata-Sponsored Clinical Trial Assesses Capability of mHealth Tools Trending Now: New study explores potential for providing patients with mobile health tools in a clinical trial setting. Medidata, a leading global provider of cloud-based solutions for clinical research in life sciences,...
By PharmaVoice Team • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

The Calendar

Coming Attractions The Healthcare Businesswomen’s Association’s (HBA) Annual Conference — Influence and Impact: Imagine the Possibilities — will take place November 3-5, 2015, at the Marriott Marquis in Atlanta. More than 1,200 executives — women and men — will convene to engage in meaningful dia...
By PharmaVoice Team • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

Talent Pool

Biotech Pool Dr. Nathalie Adda Enanta Names Chief Medical Officer Enanta Pharmaceuticals, a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, has appointed Nathalie Adda, M.D., as senior VP and chief medical ...
By PharmaVoice Team • Sept. 1, 2015
PharmaVoice Team/PharmaVoice

The Patient Journey: Moments of Care

We’ve all seen them: the patient-centric diagrams that represent as many as seven or even up to 20 stakeholders per patient, all of whom are somehow involved in that patient’s care. From drug and device manufacturers, to healthcare providers, to social media sites and even fitness centers, there ...
By Robin Robinson • Sept. 1, 2015